rs2302694

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004525.3(LRP2):​c.5100C>T​(p.Ser1700Ser) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.117 in 1,613,526 control chromosomes in the GnomAD database, including 14,569 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S1700S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.18 ( 3804 hom., cov: 32)
Exomes 𝑓: 0.11 ( 10765 hom. )

Consequence

LRP2
NM_004525.3 splice_region, synonymous

Scores

2
Splicing: ADA: 0.00001138
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.145

Publications

23 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-169231841-G-A is Benign according to our data. Variant chr2-169231841-G-A is described in ClinVar as Benign. ClinVar VariationId is 129528.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.145 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.378 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.5100C>T p.Ser1700Ser splice_region_variant, synonymous_variant Exon 31 of 79 ENST00000649046.1 NP_004516.2 P98164Q7Z5C0Q7Z5C1
LRP2XM_011511183.4 linkc.5100C>T p.Ser1700Ser splice_region_variant, synonymous_variant Exon 31 of 78 XP_011509485.1
LRP2XM_047444340.1 linkc.4176C>T p.Ser1392Ser splice_region_variant, synonymous_variant Exon 31 of 79 XP_047300296.1
LRP2XM_011511184.3 linkc.2811C>T p.Ser937Ser splice_region_variant, synonymous_variant Exon 16 of 64 XP_011509486.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.5100C>T p.Ser1700Ser splice_region_variant, synonymous_variant Exon 31 of 79 NM_004525.3 ENSP00000496870.1 P98164

Frequencies

GnomAD3 genomes
AF:
0.184
AC:
27962
AN:
151954
Hom.:
3801
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.383
Gnomad AMI
AF:
0.120
Gnomad AMR
AF:
0.188
Gnomad ASJ
AF:
0.156
Gnomad EAS
AF:
0.0548
Gnomad SAS
AF:
0.0766
Gnomad FIN
AF:
0.0417
Gnomad MID
AF:
0.155
Gnomad NFE
AF:
0.104
Gnomad OTH
AF:
0.186
GnomAD2 exomes
AF:
0.122
AC:
30634
AN:
250754
AF XY:
0.115
show subpopulations
Gnomad AFR exome
AF:
0.389
Gnomad AMR exome
AF:
0.163
Gnomad ASJ exome
AF:
0.171
Gnomad EAS exome
AF:
0.0479
Gnomad FIN exome
AF:
0.0447
Gnomad NFE exome
AF:
0.103
Gnomad OTH exome
AF:
0.126
GnomAD4 exome
AF:
0.111
AC:
161574
AN:
1461454
Hom.:
10765
Cov.:
33
AF XY:
0.109
AC XY:
79418
AN XY:
727024
show subpopulations
African (AFR)
AF:
0.395
AC:
13220
AN:
33452
American (AMR)
AF:
0.166
AC:
7410
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.162
AC:
4244
AN:
26124
East Asian (EAS)
AF:
0.0788
AC:
3128
AN:
39688
South Asian (SAS)
AF:
0.0890
AC:
7679
AN:
86254
European-Finnish (FIN)
AF:
0.0469
AC:
2503
AN:
53400
Middle Eastern (MID)
AF:
0.155
AC:
893
AN:
5754
European-Non Finnish (NFE)
AF:
0.103
AC:
114799
AN:
1111732
Other (OTH)
AF:
0.128
AC:
7698
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
7747
15494
23240
30987
38734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4410
8820
13230
17640
22050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.184
AC:
28003
AN:
152072
Hom.:
3804
Cov.:
32
AF XY:
0.178
AC XY:
13247
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.383
AC:
15859
AN:
41420
American (AMR)
AF:
0.188
AC:
2877
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
540
AN:
3466
East Asian (EAS)
AF:
0.0550
AC:
284
AN:
5168
South Asian (SAS)
AF:
0.0763
AC:
367
AN:
4812
European-Finnish (FIN)
AF:
0.0417
AC:
442
AN:
10598
Middle Eastern (MID)
AF:
0.160
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
0.104
AC:
7089
AN:
68010
Other (OTH)
AF:
0.184
AC:
389
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1048
2096
3145
4193
5241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
268
536
804
1072
1340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.127
Hom.:
5413
Bravo
AF:
0.205
Asia WGS
AF:
0.112
AC:
391
AN:
3478
EpiCase
AF:
0.109
EpiControl
AF:
0.110

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Donnai-Barrow syndrome Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.38
DANN
Benign
0.40
PhyloP100
0.14
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000011
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2302694; hg19: chr2-170088351; COSMIC: COSV55553497; API